A new federal customs regulation that limits the import of low‑cost prescription medicines from Canada will become effective later this month, and it could increase out‑of‑pocket costs for millions of U.S. consumers.
Both Democrats and Republicans have noted the upcoming rule as it restricts cross‑border purchases of cheaper Canadian drugs, which have historically helped lower prices for American buyers.
The change arrives as concerns over the cost of living are gaining attention in the run‑up to the 2026 midterm elections.